Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Entero Healthcare Solutions has filed its quarterly Reconciliation of Share Capital Audit Report for Q4FY25 (quarter ended March 31, 2025) with BSE and NSE, as required under SEBI's Depositories and Participants Regulations. The company has 4,35,07,707 total equity shares with a face value of Rs. 10, and issued, listed and total share capital are fully reconciled with no differences. All shares are held in dematerialized form — 27.25% (1,18,54,410 shares) with NSDL and 72.75% (3,16,53,297 shares) with CDSL — with zero physical shares. During the quarter, 13,940 equity shares were allotted under the Employee Stock Option Plan on January 16, 2025, and were listed on the exchanges effective February 1, 2025. The report was certified by M/s. Ranjeet Pandey & Associates, Practicing Company Secretaries.
This is a routine quarterly compliance filing with no material impact on shareholders or stock price. The minor ESOP allotment of 13,940 shares is a negligible dilution and is already reflected in the current share count.